Exclusive contract for ViroCAP My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market

EQS-News: Viromed Medical AG / Key word(s): Contract/Alliance Exclusive contract for ViroCAP My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market 25.04.2025 / 12:24 CET/CEST The issuer is solely responsible for the content of this announcement. Exclusive contract for ViroCAP My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market

Pinneberg, April 25, 2025 - Viromed Medical AG ("Viromed", Ticker: VMED; ISIN: DE000A3MQR65), a medical device company and pioneer in cold plasma technology, and Landsberg First Class Aesthetic ("Landsberg"), a leading European company for innovative cosmetic and aesthetic products based in Malta, have entered into an exclusive agreement to commercialize Viromed's cold plasma medical device ViroCAP.

Landsberg obtains exclusive distribution rights for ViroCAP in cosmetic and aesthetic applications (ViroCAP my Plasma) in Europe. The Company will market the mobile ViroCAP under its own brand and as the only device of its kind. The aim of the partnership is to bring 5,000 additional devices to the cosmetic market over the next three years, generating long-term revenue through the sale of the associated spacers.

"As a leading company in the beauty sector with a strong network of around 7,500 globally active B2B customers and 8,000-12,000 daily application requests, Landsberg opens up entry into the European cosmetics market for Viromed," says Uwe Perbandt, CEO of Viromed Medical AG. "In addition to dermatological applications in human and veterinary medicine, cold plasma technology also offers optimal application possibilities for aesthetic treatments and clinical skin care. We are very pleased to be able to further leverage the diverse product potential of ViroCAP with this partnership."

"Viromed develops innovative mobile devices to destroy viruses and bacteria and to ensure the highest level of sterility through cold plasma. This offer is particularly interesting for us, as it is an excellent addition for our spa managers, doctors, and therapists, and can significantly increase the quality of our services," comments Michael Landsberg, founder and managing director of Landsberg First Class Aesthetic. "With our partially micro-invasive treatment techniques, maintaining sterility is of the utmost importance. This leads to shorter healing phases and faster wound healing - an ideal additional service. The collaboration is based on a solid foundation and promises great success."